The Technical Analyst
Neutra Corp. [NTRR]
Exchange: PNK Industry: Biotechnology
Neutra Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0004
America/New_York / 3 mai 2024 @ 14:57
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1.167 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 2 917.90 mill |
| Avg Daily Volume: | 8.87 mill |
| RATING 2024-05-03 |
|---|
| C |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE -107.25 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-0.0003 (-183.32%) $-0.0007 |
| Date: 2024-05-04 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0004 - 0.0004 ( +/- 0.00%) |
| ATR Model: 14 days |
Forecast:
16:00 - $0.0004
Live Trading Signals (every 1 min)
Forecast
1: 15:07 - $0
Forecast 2: 15:57 - $0
Forecast 3: 16:00 - $0.0004
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0004 (0.00% ) |
| Volume | 5.26 mill |
| Avg. Vol. | 8.87 mill |
| % of Avg. Vol | 59.26 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NTRR
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NTRR
Neutra Corp. researches, develops, and provides hemp-based nutraceutical products. It offers CBD sports creams and other products. The company was incorporated in 2011 and is based in Sugar Land, Texas.
Latest Press Releases
2023-12-29 17:54:00 - Press Release
Neutra Reflects On 2023 And Looks Forward To 2024
Houston, tx, dec. 29, 2023 (globe newswire) -- via newmediawire -- neutra corporation (otc pink:ntrr), an emerging health and wellness research and development company, reflects on the 2023 year and plans for moving forward in 2024. in the previous press release, neutra announced a medium-term management plan to meet the rapidly increasing demand for the company's modern approach to specialty health and wellness solutions.
2023-10-30 10:08:00 - Press Release
Neutra Announces Strategic And Financial Value Creation Plan
Houston, tx, oct. 30, 2023 (globe newswire) -- via newmediawire - neutra corporation (otc pink: ntrr), an emerging health and wellness research and development company, announces today a two-year, medium-term management plan in order to meet the rapidly increasing demand for the company's modern approach to specialty health and wellness solutions. the strategic plan helps strengthen the shift towards the service business to grow its health and wellness portfolio and formalizes its pursuit of consulting services aimed at clinical research standards and education. the “clinical foundations” service model draws upon the multiple advances in the company's core products and will help cement its leadership of value creation in the specialty healthcare and wellness space.
2021-09-14 07:00:00 - Press Release
Latest Vivis Loi Potential First Step To Phase 1 Clinical Trial On Preventing Covid-19 Infections Using Cbd
Katy, tx / accesswire / september 14, 2021 / neutra corp. subsidiary vivis has signed a groundbreaking letter of intent (loi) with a houston clinical research company that, if it comes to a successful conclusion, would lead to testing hemp-based cannabinoids to treat covd-19. under the loi's provisions, vivis will now determine the feasibility of working with mercury clinical research to start phase 1 clinical trial on cbd efficacies in combating sars-covid-2.
2021-09-13 07:00:00 - Press Release
Latest Vivis Loi Potential First Step To Phase 1 Clinical Trial On Preventing Covid-19 Infections Using Cbd
Katy, tx / accesswire / september 13, 2021 / neutra corp. subsidiary vivis has signed a groundbreaking letter of intent (loi) with a houston clinical research company that, if it comes to a successful conclusion, would lead to testing hemp-based cannabinoids to treat covid-19. under the loi's provisions, vivis will now determine the feasibility of working with mercury clinical research to start phase 1 clinical trial on cbd efficacies in combating sars-covid-2.
2021-08-16 07:00:00 - Press Release
Neutra Corp. Provides Strategic Update
Katy, tx / accesswire / august 16, 2021 / neutra corp. (otc pink:ntrr) continues to make substantial progress in securing distribution for its wholly-owned subsidiary vivis' cbd products. since announcing this strategy in january, neutra management has successfully placed vivis in festival foods, a large 35 store regional supermarket chain.
Latest News
2021-09-14 07:00:00 - Accesswire
Latest VIVIS LOI Potential First Step to Phase 1 Clinical Trial on Preventing COVID-19 Infections Using CBD
KATY, TX / ACCESSWIRE / September 14, 2021 / Neutra Corp. subsidiary VIVIS has signed a groundbreaking letter of intent (LOI) with a Houston clinical research company that, if it comes to a successful conclusion, would lead to testing hemp-based cannabinoids to treat COVD-19. Under the LOI's provisions, VIVIS will now determine the feasibility of working with Mercury Clinical Research to start phase 1 clinical trial on CBD efficacies in combating SARS-COVID-2.
2021-09-13 07:00:00 - Accesswire
Latest VIVIS LOI Potential First Step to Phase 1 Clinical Trial on Preventing COVID-19 Infections Using CBD
KATY, TX / ACCESSWIRE / September 13, 2021 / Neutra Corp. subsidiary VIVIS has signed a groundbreaking letter of intent (LOI) with a Houston clinical research company that, if it comes to a successful conclusion, would lead to testing hemp-based cannabinoids to treat COVID-19. Under the LOI's provisions, VIVIS will now determine the feasibility of working with Mercury Clinical Research to start phase 1 clinical trial on CBD efficacies in combating SARS-COVID-2.
2021-08-16 07:00:00 - Accesswire
Neutra Corp. Provides Strategic Update
KATY, TX / ACCESSWIRE / August 16, 2021 / Neutra Corp. (OTC PINK:NTRR) continues to make substantial progress in securing distribution for its wholly-owned subsidiary VIVIS' CBD products. Since announcing this strategy in January, Neutra management has successfully placed VIVIS in Festival Foods, a large 35 store regional supermarket chain.
2021-08-02 10:25:00 - Accesswire
VIVIS-Brand CBD Products Will Be Available at Festival Foods Flagship Store
KATY, TX / ACCESSWIRE / August 2, 2021 / Neutra Corp. (OTC PINK:NTRR) announces it has been officially accepted in a well-known Wisconsin grocery company for Neutra's CBD products to be sold at its stores, starting initially with the chain's flagship location on August 9, 2021. This means that Festival Food shoppers can find and buy VIVIS-branded items at the company's Onalaska store, about halfway between Madison, Wisconsin, and Minneapolis.
2021-07-13 12:10:00 - Accesswire
VIVIS-Brand CBD Products Will Soon Be Available at Mid-West Grocery Chain Flagship Store
KATY, TX / ACCESSWIRE / July 13, 2021 / Neutra Corp. (OTC PINK:NTRR) announces it has been officially accepted in a large, well-known Mid-West grocery company for Neutra's CBD products to be sold at its stores, starting initially with the chain's flagship location. VIVIS has submitted its compliance packet and hope to be in the store in the next few weeks.
2021-05-28 15:55:00 - Accesswire
Neutra On To The Next Step With Mexican Distributor
KATY, TX / ACCESSWIRE / May 28, 2021 / Neutra Corp. (OTC PINK:NTRR) VIVIS CBD manufactured has passed the next step with striking a deal with a Mexican company for distribution in Mexico. Once this agreement is executed the doors will open for Neutra and VIVIS in an international scale and hopefully use the momentum to reach other countries.
2021-05-19 14:00:00 - Accesswire
Neutra to Target Baby Boomers in Home Health and Hospice Care Bid
KATY, TX / ACCESSWIRE / May 19, 2021 / Neutra Corp. (OTC PINK:NTRR) is closely examining options to enter the home health and hospice care business. The company believes the market offers a potentially sizeable opportunity for CBD products aimed at aging members of the Baby Boomer generation now retiring in large numbers.
2021-05-13 14:00:00 - Accesswire
VIVIS CBD Gets First-Round Approval Enroute to Becoming Big Box Store Vendor
KATY, TX / ACCESSWIRE / May 13, 2021 / Neutra Corp. (OTC PINK:NTRR) is moving to the second step in the process of gaining acceptance as a vendor at one of three regional big box store chains. Upon successful completion, Neutra subsidiary VIVIS will be able to stock store shelves with its lab-tested CBD products and gain access to a wide range of new customers.
2021-05-07 14:00:00 - Accesswire
Pasadena Pharmacy Becomes the Latest Retailer to Offer VIVIS CBD Products
KATY, TX / ACCESSWIRE / May 7, 2021 / Neutra Corp. (OTC PINK:NTRR) has been accepted as a vendor for the Pasadena Medical Plaza Pharmacy in Pasadena, TX, and the store will have VIVIS-Branded CBD products in stock starting May 12, 2021. "This is another win for VIVIS and our sales team," said Neutra CEO Sydney Jim.
2021-05-05 07:00:00 - Accesswire
Houston-Area Wellness Center Nearly Sells Out of VIVIS Products During Launch Party
KATY, TX / ACCESSWIRE / May 5, 2021 / Neutra Corp. (OTC PINK:NTRR) held a successful launch party May 1 at its newest retail partner's Houston-area store and reports the retailer sold nearly all of its initial order of VIVIS products to an enthusiastic crowd. The store, Restore Hyper Wellness, is already preparing to place a followup order for additional VIVIS products.